Data / Drug companies / Linezolid
Linezolid: 28 companies and 40 products in the FDA NDC directory
Linezolid is listed in the FDA National Drug Code Directory by 28 companies, with 40 products in commercial distribution. 31 of the products (77.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; tablet, film coated; tablet, and the newest product started marketing on December 23, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 28
- Products
- 40
- Generic (ANDA) products
- 31 (77.5%)
- Application numbers
- 20
- Routes
- Oral, Intravenous
- Brand names
- Zyvox
- openFDA record search
- api.fda.gov
Companies that list linezolid
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Hp Halden Pharma As | 4 | injection, solution; injection | New drug applications (NDA) | June 5, 2018 |
| Pharmacia & Upjohn Company LLC | 4 | injection, solution; tablet, film coated | New drug applications (NDA) | October 12, 2015 |
| American Health Packaging | 2 | tablet, film coated; granule, for suspension | Generic drugs (ANDA) | August 20, 2023 |
| Camber Pharmaceuticals, Inc. | 2 | tablet, film coated; granule, for suspension | Generic drugs (ANDA) | October 31, 2022 |
| Piramal Critical Care Inc | 2 | injection, solution; injection | Generic drugs (ANDA) | March 8, 2024 |
| Sandoz Inc | 2 | injection, solution | Generic drugs (ANDA) | June 15, 2016 |
| Sportpharm LLC | 2 | tablet, film coated; tablet | Generic drugs (ANDA) | November 20, 2023 |
| Sun Pharmaceutical Industries, Inc. | 2 | injection, solution | Generic drugs (ANDA) | February 1, 2017 |
| A-S Medication Solutions | 1 | tablet, film coated | Generic drugs (ANDA) | December 21, 2015 |
| Alembic Pharmaceuticals Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | December 22, 2015 |
| Alembic Pharmaceuticals Limited | 1 | tablet, film coated | Generic drugs (ANDA) | December 22, 2015 |
| Ascend Laboratories, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | December 21, 2015 |
| Bryant Ranch Prepack | 1 | tablet, film coated | Generic drugs (ANDA) | December 21, 2015 |
| Bryant Ranch Prepack | 1 | tablet, film coated | Generic drugs (ANDA) | December 21, 2015 |
| Caplin Steriles Limited | 1 | injection, solution | Generic drugs (ANDA) | December 23, 2025 |
| Chartwell RX, LLC | 1 | tablet | Generic drugs (ANDA) | April 25, 2019 |
| Coupler LLC | 1 | tablet, film coated | Generic drugs (ANDA) | September 4, 2025 |
| Eugia US LLC | 1 | injection, solution | Generic drugs (ANDA) | August 4, 2016 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | June 22, 2015 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection, solution | Generic drugs (ANDA) | December 27, 2022 |
| Hikma Pharmaceuticals USA Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | June 3, 2015 |
| Hospira, Inc. | 1 | injection, solution | New drug applications (NDA) | June 18, 2015 |
| Lupin Pharmaceuticals,Inc. | 1 | tablet | Generic drugs (ANDA) | August 22, 2016 |
| Macleods Pharmaceuticals Limited | 1 | tablet, coated | Generic drugs (ANDA) | October 10, 2024 |
| Major Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | December 21, 2015 |
| Mylan Pharmaceuticals Inc. | 1 | suspension | Authorized generics (NDA) | May 18, 2015 |
| Remedyrepack Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | May 8, 2024 |
| Rising Pharma Holdings, Inc. | 1 | tablet | Generic drugs (ANDA) | November 20, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 15 | 37.5% |
| Tablet, film coated | 13 | 32.5% |
| Tablet | 4 | 10% |
| Granule, for suspension | 3 | 7.5% |
| Injection | 2 | 5% |
| Powder, for suspension | 1 | 2.5% |
| Tablet, coated | 1 | 2.5% |
| Suspension | 1 | 2.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 31 | 77.5% |
| New drug applications (NDA) | 8 | 20% |
| Authorized generics (NDA) | 1 | 2.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Oxazolidinone Antibacterial | 40 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.